Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
PPLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Piramal Pharma has informed the stock exchanges about its upcoming schedule of meetings with analysts and institutional investors, as required under SEBI LODR Regulation 30(6). Two meetings are planned: a JM Financial Promotor Conference on 18th August 2025 and the Motilal Oswal 21st Annual Global Investor Conference on 2nd September 2025, both to be held in Mumbai. The meetings will include group and one-on-one sessions with investors in person. The company noted that the dates are subject to change depending on exigencies.
This is a routine regulatory disclosure and typically has no direct impact on stock price. However, it signals that Piramal Pharma is actively engaging with broker conferences and institutional investors, which can help improve analyst coverage and investor visibility.